enVVeno Medical (NVNO) Equity Average (2018 - 2026)

enVVeno Medical's Equity Average history runs 9 years deep, the most recent figure standing at $25.4 million for Q1 2026.

• In Q1 2026, Equity Average fell 36.77% year-over-year to $25.4 million; the TTM figure through Mar 2026 stood at $25.4 million (down 36.77% YoY), while the FY2025 annual figure was $34.6 million, down 21.58% from the prior year.
• Equity Average was $25.4 million for Q1 2026 at enVVeno Medical, down from $28.3 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $52.9 million in Q1 2022 to a low of $25.4 million in Q1 2026.
• Historically, Equity Average has averaged $38.3 million across 5 years, with a median of $40.2 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Equity Average soared 110.98% in 2022, then sank 39.79% in 2023.
• A 5-year view of Equity Average shows it stood at $40.7 million in 2022, then fell by 12.64% to $35.6 million in 2023, then rose by 25.89% to $44.8 million in 2024, then plunged by 36.81% to $28.3 million in 2025, then retreated by 10.07% to $25.4 million in 2026.
• The last three Equity Average figures came in at $25.4 million (Q1 2026), $28.3 million (Q4 2025), and $31.3 million (Q3 2025), per Business Quant data.